Cited by — Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS.
No admitted local citation edges point to this work yet.
